Complement activation in acetaminophen-induced liver injury in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 341, Issue 2, 2012, Pages 377-385

  Singhal, Rohit ^a   Ganey, Patricia E ^a   Roth, Robert A ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; COBROTOXIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; GLUTATHIONE; SODIUM CHLORIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CELL VIABILITY; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 10 GENE; INTERLEUKIN 6 GENE; LIVER CELL CULTURE; LIVER INJURY; LIVER METABOLISM; LIVER NECROSIS; LIVER PARENCHYMA; LIVER TOXICITY; MALE; MOLECULAR PATHOLOGY; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PLASMINOGEN ACTIVATION INHIBITOR 1 GENE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C3B; DRUG-INDUCED LIVER INJURY; GLUTATHIONE; INTERLEUKIN-10; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, INBRED C57BL; NECROSIS; NEUTROPHILS; OVERDOSE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 84859977248     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.189837     Document Type: Article

References (48)

1. Aibo DI, Birmingham NP, Lewandowski R, Maddox JF, Roth RA, Ganey PE, Wagner JG, and Harkema JR (2010) Acute exposure to ozone exacerbates acetaminopheninduced liver injury in mice. Toxicol Sci 115:267-285.
2. Alper CA and Balavitch D (1976) Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement). Science 191:1275-1276.
3. Bajt ML, Yan HM, Farhood A, and Jaeschke H (2008) Plasminogen activator inhibitor-1 limits liver injury and facilitates regeneration after acetaminophen overdose. Toxicol Sci 104:419-427. (Pubitemid 352038264)
4. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81:1-5.
5. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, and Luster MI (1995) Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 133:43-52.
6. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, and Pohl LR (2002) Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35:289-298. (Pubitemid 34106367)
7. Cai C, Gill R, Eum HA, Cao Z, Loughran PA, Darwiche S, Edmonds RD, Menzel CL, and Billiar TR (2010) Complement factor 3 deficiency attenuates hemorrhagic shock-related hepatic injury and systemic inflammatory response syndrome. Am J Physiol Regul Integr Comp Physiol 299:R1175-R1182.
8. Chiu H, Gardner CR, Dambach DM, Brittingham JA, Durham SK, Laskin JD, and Laskin DL (2003) Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense. Am J Physiol Gastrointest Liver Physiol 285:G959-G966. (Pubitemid 37310075)
9. Clapperton M, Rolando N, Sandoval L, Davies E, and Williams R (1997) Neutrophil superoxide and hydrogen peroxide production in patients with acute liver failure. Eur J Clin Invest 27:164-168. (Pubitemid 27101389)
10. Cohen JI, Roychowdhury S, McMullen MR, Stavitsky AB, and Nagy LE (2010) Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology 139:664-674, 674.e1.
11. Dambach DM, Watson LM, Gray KR, Durham SK, and Laskin DL (2002) Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35:1093-1103. (Pubitemid 34454006)
12. Dear JW, Simpson KJ, Nicolai MP, Catterson JH, Street J, Huizinga T, Craig DG, Dhaliwal K, Webb S, Bateman DN, et al. (2011) Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury. J Immunol 187:3347-3352.
13. Ellison RT 3rd, Horsburgh CR Jr, and Curd J (1990) Complement levels in patients with hepatic dysfunction. Dig Dis Sci 35:231-235.
14. Fausto N (2000) Liver regeneration. J Hepatol 32 (Suppl 1):19-31.
15. Ganey PE, Luyendyk JP, Newport SW, Eagle TM, Maddox JF, Mackman N, and Roth RA (2007) Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology 46:1177-1186. (Pubitemid 350144782)
16. Gardner CR, Laskin JD, Dambach DM, Chiu H, Durham SK, Zhou P, Bruno M, Gerecke DR, Gordon MK, and Laskin DL (2003) Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol Appl Pharmacol 192:119-130. (Pubitemid 37194516)
17. He S, Atkinson C, Qiao F, Cianflone K, Chen X, and Tomlinson S (2009) A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice. J Clin Invest 119:2304-2316.
18. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, Flavell RA, and Mehal WZ (2009) Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 119:305-314.
19. Jaeschke H (2008) Innate immunity and acetaminophen-induced liver injury: why so many controversies? Hepatology 48:699-701.
20. Jaeschke H, McGill MR, Williams CD, and Ramachandran A (2011) Current issues with acetaminophen hepatotoxicity-a clinically relevant model to test the efficacy of natural products. Life Sci 88:737-745.
21. James LP, Lamps LW, McCullough S, and Hinson JA (2003) Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem Biophys Res Commun 309:857-863. (Pubitemid 37122608)
22. Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, George JW, and Pohl LR (2002) Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol 15:1504-1513. (Pubitemid 36008198)
23. Kaplowitz N (2004) Acetaminophen hepatoxicity: what do we know, what don't we know, and what do we do next? Hepatology 40:23-26.
24. Kastl SP, Speidl WS, Kaun C, Rega G, Assadian A, Weiss TW, Valent P, Hagmueller GW, Maurer G, Huber K, et al. (2006) The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-κBactivation. J Thromb Haemost 4:1790-1797. (Pubitemid 44144807)
25. Koleva M, Schlaf G, Landmann R, Götze O, Jungermann K, and Schieferdecker HL (2002) Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from Kupffer cells. Gastroenterology 122:697-708. (Pubitemid 34173822)
26. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiødt FV, Ostapowicz G, Shakil AO, et al. (2005) Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42:1364-1372. (Pubitemid 43260039)
27. Laskin DL, Gardner CR, Price VF, and Jollow DJ (1995) Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21: 1045-1050.
28. Lawson JA, Farhood A, Hopper RD, Bajt ML, and Jaeschke H (2000) The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 54:509-516. (Pubitemid 30185974)
29. Lee WM (2004) Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 40:6-9.
30. Liu ZX, Han D, Gunawan B, and Kaplowitz N (2006) Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 43:1220-1230. (Pubitemid 43980100)
31. Markiewski MM, DeAngelis RA, Strey CW, Foukas PG, Gerard C, Gerard N, Wetsel RA, and Lambris JD (2009) The regulation of liver cell survival by complement. J Immunol 182:5412-5418.
32. Markiewski MM, Mastellos D, Tudoran R, DeAngelis RA, Strey CW, Franchini S, Wetsel RA, Erdei A, and Lambris JD (2004) C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol 173:747-754. (Pubitemid 38924248)
33. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, and Lambris JD (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28: 184-192. (Pubitemid 46476881)
34. Martin-Murphy BV, Holt MP, and Ju C (2010) The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. Toxicol Lett 192:387-394.
35. Mastellos D, Papadimitriou JC, Franchini S, Tsonis PA, and Lambris JD (2001) A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol 166:2479-2486. (Pubitemid 32173484)
36. Mastellos D, Prechl J, László G, Papp K, Oláh E, Argyropoulos E, Franchini S, Tudoran R, Markiewski M, Lambris JD, et al. (2004) Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Mol Immunol 40:1213-1221. (Pubitemid 38210273)
37. Masubuchi Y, Bourdi M, Reilly TP, Graf ML, George JW, and Pohl LR (2003) Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun 304:207-212. (Pubitemid 36434217)
38. Navratil JS, Liu CC, and Ahearn JM (2006) Apoptosis and autoimmunity. Immunol Res 36:3-12. (Pubitemid 46398605)
39. Pepys MB (1975) Studies in vivo of cobra factor and murine C3. Immunology 28:369-377.
40. Prohászka Z, Singh M, Nagy K, Kiss E, Lakos G, Duba J, and Füst G (2002) Heat shock protein 70 is a potent activator of the human complement system. Cell Stress Chaperones 7:17-22.
41. Rawal N and Pangburn MK (2001) Structure/function of C5 convertases of complement. Int Immunopharmacol 1:415-422. (Pubitemid 32197540)
42. Rensen SS, Slaats Y, Driessen A, Peutz-Kootstra CJ, Nijhuis J, Steffensen R, Greve JW, and Buurman WA (2009) Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology 50:1809-1817.
43. Roychowdhury S, McMullen MR, Pritchard MT, Hise AG, van Rooijen N, Medof ME, Stavitsky AB, and Nagy LE (2009) An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology 49:1326-1334.
44. Scaffidi P, Misteli T, and Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195. (Pubitemid 34773774)
45. Singhal R, Badger TM, and Ronis MJ (2009) Estrogenic status modulates the effect of soy on hepatic responses to 7,12-dimethylbenz(a)anthracene (DMBA). Toxicol Appl Pharmacol 234:89-97.
46. Walport MJ (2001) Complement. Second of two parts. N Engl J Med 344:1140-1144.
47. Ward PA (2004) The dark side of C5a in sepsis. Nat Rev Immunol 4:133-142.
48. Yee SB, Hanumegowda UM, Hotchkiss JA, Ganey PE, and Roth RA (2003) Role of neutrophils in the synergistic liver injury from monocrotaline and bacterial lipopolysaccharide exposure. Toxicol Sci 72:43-56. (Pubitemid 36336433)